Literature DB >> 21441480

Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

P L Fidel1.   

Abstract

Oropharyngeal candidiasis (OPC), caused primarily by Candida albicans, is the most common oral infection in HIV(+) persons. Although Th1-type CD4(+) T cells are the predominant host defense mechanism against OPC, CD8(+) T cells and epithelial cells become important when blood CD4(+) T cells are reduced below a protective threshold during progression to AIDS. In an early cross-sectional study, OPC(+) tissue biopsied from HIV(+) persons had an accumulation of activated memory CD8(+) T cells at the oral epithelial-lamina propria interface, with reduced expression of the adhesion molecule E-cadherin, suggesting a protective role for CD8(+) T cells but a dysfunction in the mucosal migration of the cells. In a subsequent 1-year longitudinal study, OPC(-) patients with high oral Candida colonization (indicative of a preclinical OPC condition), had higher numbers of CD8(+) T cells distributed throughout the tissue, with normal E-cadherin expression. In OPC(+) patients, where lack of CD8(+) T cell migration was associated with reduced E-cadherin, subsequent evaluations following successful treatment of infection revealed normal E-cadherin expression and cellular distribution. Regarding epithelial cell responses, intact oral epithelial cells exhibit fungistatic activity via an acid-labile protein moiety. A proteomic analysis revealed that annexin A1 is a strong candidate for the effector moiety. The current hypothesis is that under reduced CD4(+) T cells, HIV(+) persons protected from OPC have CD8(+) T cells that migrate to the site of a preclinical infection under normal expression of E-cadherin, whereas those with OPC have a transient reduction in E-cadherin that prohibits CD8(+) T cells from migrating for effector function. Oral epithelial cells concomitantly function through annexin A1 to keep Candida in a commensal state but can easily be overwhelmed, thereby contributing to susceptibility to OPC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441480      PMCID: PMC3144040          DOI: 10.1177/0022034511399284

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  49 in total

1.  Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence.

Authors:  Martin Schaller; Reinhard Mailhammer; Guntram Grassl; Christian A Sander; Bernhard Hube; Hans C Korting
Journal:  J Invest Dermatol       Date:  2002-04       Impact factor: 8.551

Review 2.  Chronic mucocutaneous candidiasis: model-building in cellular immunity.

Authors:  C H Kirkpatrick; R R Rich; J E Bennett
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

3.  A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.

Authors:  Karen L Wozniak; Janet E Leigh; Shannon Hager; Rolf K Swoboda; Paul L Fidel
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

4.  Vaginal and oral epithelial cell anti-Candida activity.

Authors:  Fatema Nomanbhoy; Chad Steele; Junko Yano; Paul L Fidel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation.

Authors:  Mahmoud Rouabhia; Geneviève Ross; Nathalie Pagé; Jamila Chakir
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Candida albicans triggers interleukin-8 secretion by oral epithelial cells.

Authors:  A Dongari-Bagtzoglou; H Kashleva
Journal:  Microb Pathog       Date:  2003-04       Impact factor: 3.738

7.  Humoral immunity in vaginal candidiasis.

Authors:  S Mathur; G V Koistinen; E O Horger; T A Mahvi; H H Fudenberg
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis.

Authors:  Elizabeth A Lilly; Darrenn J Hart; Janet E Leigh; Shannon Hager; Kelly M McNulty; Donald E Mercante; Paul L Fidel
Journal:  J Infect Dis       Date:  2004-06-25       Impact factor: 5.226

9.  Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans.

Authors:  A Dongari-Bagtzoglou; H Kashleva
Journal:  Oral Microbiol Immunol       Date:  2003-06

10.  Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.

Authors:  Tammy A Myers; Janet E Leigh; Alfredo R Arribas; Shannon Hager; Rebecca Clark; Elizabeth Lilly; Paul L Fidel
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

View more
  53 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 2.  Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Authors:  Natasha Whibley; Sarah L Gaffen
Journal:  Cytokine       Date:  2015-08-11       Impact factor: 3.861

3.  IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis.

Authors:  Heather R Conti; Vincent M Bruno; Erin E Childs; Sean Daugherty; Joseph P Hunter; Bemnet G Mengesha; Danielle L Saevig; Matthew R Hendricks; Bianca M Coleman; Lucas Brane; Norma Solis; J Agustin Cruz; Akash H Verma; Abhishek V Garg; Amy G Hise; Jonathan P Richardson; Julian R Naglik; Scott G Filler; Jay K Kolls; Satrajit Sinha; Sarah L Gaffen
Journal:  Cell Host Microbe       Date:  2016-10-27       Impact factor: 21.023

Review 4.  IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

5.  Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis.

Authors:  Felix E Y Aggor; Timothy J Break; Giraldina Trevejo-Nuñez; Natasha Whibley; Bianca M Coleman; Rachel D Bailey; Daniel H Kaplan; Julian R Naglik; Wei Shan; Amol C Shetty; Carrie McCracken; Scott K Durum; Partha S Biswas; Vincent M Bruno; Jay K Kolls; Michail S Lionakis; Sarah L Gaffen
Journal:  Sci Immunol       Date:  2020-06-05

6.  Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model.

Authors:  Patricia I Diaz; Zhihong Xie; Takanori Sobue; Angela Thompson; Basak Biyikoglu; Austin Ricker; Laertis Ikonomou; Anna Dongari-Bagtzoglou
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

7.  Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.

Authors:  Natasha Whibley; Elaine Tritto; Elisabetta Traggiai; Frank Kolbinger; Pierre Moulin; Dominique Brees; Bianca M Coleman; Anna J Mamo; Abhishek V Garg; Jillian R Jaycox; Ulrich Siebenlist; Michael Kammüller; Sarah L Gaffen
Journal:  J Leukoc Biol       Date:  2016-01-04       Impact factor: 4.962

8.  HIV infection and microbial diversity in saliva.

Authors:  Yihong Li; Deepak Saxena; Zhou Chen; Gaoxia Liu; Willam R Abrams; Joan A Phelan; Robert G Norman; Gene S Fisch; Patricia M Corby; Floyd Dewhirst; Bruce J Paster; Alexis S Kokaras; Daniel Malamud
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

9.  Effect of Nitric Oxide on the Antifungal Activity of Oxidative Stress and Azoles Against Candida albicans.

Authors:  De-Dong Li; Chang-Chun Yang; Ping Liu; Yan Wang; Yan Sun
Journal:  Indian J Microbiol       Date:  2016-04-09       Impact factor: 2.461

10.  Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.

Authors:  Eric F Kong; Christina Tsui; Heather Boyce; Ahmed Ibrahim; Stephen W Hoag; Amy J Karlsson; Timothy F Meiller; Mary Ann Jabra-Rizk
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.